References and Notes
1 Brock ED, Lewis DM, Yousaf TI, Harper HH, and . inventors; WO9951688.
; Chem. Abstr. 1999, 131, 287743
2a
Beagley P.
Blackie MAL.
Chibale K.
Clarkson C.
Meijboom R.
Moss JR.
Smith P.
Su H.
Dalton Trans.
2003,
3046
2b
Sawada Y.
Kayakiri H.
Abe Y.
Mizutani T.
Inamura N.
Asano M.
Hatori C.
Aramori I.
Oku T.
Tanaka H.
J. Med. Chem.
2004,
47:
2853
2c
Ma Z.
Hano Y.
Nomura T.
Chen Y.
Bioorg. Med. Chem. Lett.
2004,
14:
1193
2d
Denton TT.
Zhang X.
Cashman JR.
J. Med. Chem.
2005,
48:
224
2e
Fokialakis N.
Magiatis P.
Chinou L.
Mitaku S.
Tillequin F.
Chem. Pharm. Bull.
2002,
50:
413
2f
Fossa P.
Mosti L.
Menozzi G.
Marzano C.
Baccichetti F.
Bordin F.
Bioorg. Med. Chem.
2002,
10:
743
2g
Ryckebusch A.
Derprez-Poulain R.
Maes L.
Debreu-Fontaine MA.
Mouray E.
Grellier P.
Sergheraert C.
J. Med. Chem.
2003,
46:
542
2h
Morgan LR.
Jursic BS.
Hooper CL.
Neumann DM.
Thangaraj K.
Leblanc B.
Bioorg. Med. Chem. Lett.
2002,
12:
3407
3
Sakata G.
Makino K.
Karasawa Y.
Heterocycles
1988,
27:
2481
4a
Demeunynck M.
Moucheron C.
Mesmaeker AK.-D.
Tetrahedron Lett.
2002,
43:
261
4b
Baraznenok IL.
Nenajdenko VG.
Balenkova ES.
Eur. J. Org. Chem.
1999,
937
4c
Ali MM.
Tasneem KC.
Rajanna PK.
Prakash S.
Synlett
2001,
251
4d
Palacios F.
Ochoa de Retana AM.
Oyarzabal J.
Tetrahedron
1999,
55:
5947
4e
Charpentier P.
Lobregat V.
Levacher V.
Dupas G.
Queguiner G.
Bourguignon J.
Tetrahedron Lett.
1998,
39:
4013
4f
Cho CS.
Kim BT.
Kim TJ.
Shim SC.
Chem. Commun.
2001,
2576
4g
Uchiyama K.
Hayashi Y.
Narasaka K.
Synlett
1997,
445
4h
Crousse B.
Begue J.-P.
Bonnet-Delpon D.
J. Org. Chem.
2000,
65:
5009
4i
Lin XF.
Cui SL.
Wang YG.
Tetrahedron Lett.
2006,
47:
4509
4j
Lin XF.
Cui SL.
Wang YG.
Tetrahedron Lett.
2006,
47:
3127
5a
Skraup H.
Chem. Ber.
1880,
13:
2086
5b
Mansake RH.
Kulka M.
Org. React. (N.Y.)
1953,
7:
59
5c
Doebner O.
Miller VW.
Chem. Ber.
1881,
14:
2812
5d
Conrad M.
Limbach L.
Chem. Ber.
1887,
20:
944
5e
Combes A.
C. R. Hebd. Seances Acad. Sci.
1888,
106:
142
5f
Pfitzinger W.
J. Prakt. Chem.
1886,
33:
100
6a
Wang XS.
Zhang MM.
Jiang H.
Shi DQ.
Tu SJ.
Wei XY.
Zong ZM.
Synthesis
2006,
4187
6b
Wang XS.
Zhang MM.
Jiang H.
Yao CS.
Tu SJ.
Tetrahedron
2007,
63:
4439
6c
Wang XS.
Zhang MM.
Jiang H.
Yao CS.
Tu SJ.
Tetrahedron
2007,
63:
5265
7a
Jin T.-S.
Zhang J.-S.
Guo T.-T.
Wang A.-Q.
Li T.-S.
Synthesis
2004,
2001
7b
Azizian J.
Hatamjafari F.
Karimi AR.
Shaabanzadeh M.
Synthesis
2006,
765
7c
Jin T.-S.
Xiao J.-C.
Wang S.-J.
Li T.-S.
Song X.-R.
Synlett
2003,
2001
8a
Wang XS.
Zhang MM.
Shi DQ.
Tu SJ.
Wei XY.
Zong ZM.
Tetrahedron Lett.
2005,
46:
7169
8b
Wang XS.
Zhang MM.
Shi DQ.
T u SJ.
Wei XY.
Zong ZM.
Chem. Lett.
2005,
34:
1316
8c
Wang XS.
Zhang MM.
Jiang H.
Li Q.
Shi DQ.
Tu SJ.
Chem. Lett.
2007,
36:
450
8d
Wang XS.
Zhang MM.
Shi DQ.
Tu SJ.
Wei XY.
Zong ZM.
J. Heterocycl. Chem.
2007,
36:
441
9
General Procedure for the Syntheses of 1-Aryl-1,4-dihydro-3-[(
E
)-2-hydroxyprop-1-enyl]-
N
-(naphthalene-2-yl)benzo[
f
]quinoline-2-carboxamide Derivatives: A 50-mL flask was charged with N-arylidenenaphthalen-2-amine (2.0 mmol), 4-hydroxy-6-methylpyran-2-one (2.0 mmol, 0.252 g), naphthalen-2-amine (2.0 mmol, 0.286 g), TEBAC (0.2 mmol, 0.046 g), and H2O (10 mL). The reaction mixture was stirred at 90 °C for 10-16 h; the solid was isolated by filtration. The filtrate together with TEBAC could be used directly for subsequent runs of the same reaction. The crude products were washed with H2O and purified by recrystallization from DMF and H2O, and then dried at 80 °C for several hours under vacuum to give compound 3. Selected data: 1,4-Dihydro-1-(3,4-dimethoxyphenyl)-3-[(E)-2-hydroxyprop-1-enyl)-N-(naphthalene-2-yl)benzo[f]quinoline-2-carboxamide (3a): mp 241-243 °C. 1H NMR (DMSO-d
6): δ = 2.13 (s, 3 H, Me), 3.66 (s, 3 H, MeO), 3.71 (s, 1 H, OH), 3.75 (s, 3 H, MeO), 5.34 (s, 1 H, CH), 5.61 (s, 1 H, CH), 6.36 (dd, J = 8.4 Hz, J′ = 2.0 Hz, 1 H, ArH), 6.75 (d, J = 8.4 Hz, 1 H, ArH), 7.02 (d, J = 2.0 Hz, 1 H, ArH), 7.25 (d, J = 8.8 Hz, 1 H, ArH), 7.31-7.36 (m, 2 H, ArH), 7.43-7.51 (m, 3 H, ArH), 7.70 (d, J = 2.0 Hz, 1 H, ArH), 7.82-7.89 (m, 6 H, ArH), 10.59 (s, 1 H, NH), 12.31 (s, 1 H, NH). 13C NMR (DMSO-d
6): δ = 20.5, 55.9, 56.0, 62.0, 95.2, 111.9, 112.4, 117.4, 117.6, 119.2, 121.5, 123.3, 123.4, 123.9, 124.3, 126.2, 127.2, 127.4, 127.9, 128.0, 128.9, 129.0, 129.3, 130.5, 131.2, 131.7, 133.6, 134.8, 135.7, 135.9, 148.1, 149.5, 162.4, 167.7, 190.3. HRMS (EI): m/z [M+] calcd for C35H30N2O4: 542.2206; found: 542.2220. IR (KBr): 3109, 3060, 3052, 2947, 2832, 1681, 1612, 1598, 1516, 1466, 1451, 1393, 1374, 1331, 1286, 1254, 1203, 1183, 1138, 1124, 1027, 845, 815, 789, 746 cm-1.